#7: StockPro: Interview with Joseph M. Cummings Joseph M. Cummings, President & CEO of Amarillo Biosciences, Inc. has... |
March 20, 2007 01:58:29 PM |
#6: NewsBot: AMAR News Dutton Associates Announces Investment Opinion: Amarillo Biosciences Speculative Buy Rating Reiterated in Update Report by Dutton Associates EL DORADO HILLS, Calif.--(BUSINESS WIRE)--Dutton Associates updates its coverage... |
December 1, 2006 09:00:00 AM |
#5: NewsBot: AMAR News Dutton Associates Announces Investment Opinion: Amarillo Biosciences Rating Speculative Buy in Initiating Coverage by Dutton Associates EL DORADO HILLS, Calif.--(BUSINESS WIRE)--Sept. 18, 2006--Dutton Associates... |
September 18, 2006 01:26:00 PM |
#4: NewsBot: AMAR News Management Team of Amarillo Biosciences, Inc., Discuss Upcoming Studies and Successful Passing of FDA's 30-day Review Process for Company's Investigational New Drug Application for Idiopathic Pulmonary Fibrosis at SmallCapVoice.com AUSTIN, Texas--(BUSINESS WIRE)--Aug. 17, 2006--SmallCapVoice.com, Inc. today... |
August 17, 2006 06:06:00 AM |
#3: NewsBot: AMAR News Joseph Cummins, President and CEO of Amarillo Biosciences, Inc., Discusses Recent News in an Audio Interview at SmallCapVoice.com AUSTIN, Texas--(BUSINESS WIRE)--Aug. 10, 2006--SmallCapVoice.com, Inc. today... |
August 10, 2006 05:30:00 AM |
#2: NewsBot: AMAR Amarillo Biosciences Message Board, News, Quotes, DD Amarillo Biosciences Enters Into Agreement to Commercialize Low Dose Oral... |
December 11, 2005 04:47:19 PM |
#1: NewsBot: AMAR News Research Amarillo Biosciences Inc,Stock Trading Message Board Amarillo Biosciences Issues Progress Report
Amarillo Biosciences, Inc. (OTC BB:... |
October 8, 2005 08:49:36 AM |